Screening for Colorectal Cancer Bruce D. Greenwald, MD Associate Professor of Medicine University of Maryland School of Medicine and Greenebaum Cancer.

Slides:



Advertisements
Similar presentations
Colon and Rectal Cancer Update
Advertisements

Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
Spotlight on Colorectal Cancer Screening 1 1. Home Screening for Colon Cancer
EQUIP Training session 1
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Colorectal Cancer Screening & Surveillance: Anything New? Timothy C. Hoops, M.D.
CT COLONOSCOPY. Turki Alhazmi,MB.CHB, FRCPC, dABR Interventional Radiology-Body MRI Ass. Prof. Faculty of Medicine Umm Al Qura University Makkah-Saudi.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.

Dietary intakes of calcium and vitamin D and risk of colorectal cancer in women Jennifer Lin, PhD Division of Preventive Medicine Brigham and Women’s Hospital.
Screening for colorectal cancers What ’ s new?. Screening Routine examination of asymptomatic population of a disease Routine examination of asymptomatic.
Screening and Early Diagnosis of Colorectal Cancer
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Joint Hospital Surgical Grand Round 19 June 2004.
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Update on Colon Cancer Screening and Prevention
A Call to Action: Prevention and Early Detection of Colorectal Cancer (CRC)
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
Tryggvi Björn Stefánsson Dept of Surgery Landspitali University Hospital.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Colorectal cancer Khayal AlKhayal MD,FRCSC
General Medicine Subspecialty Conference Colon Cancer Screening General Medicine Subspecialty Conference Colon Cancer Screening Selim Krim, MD Assistant.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Benchmarking For Colonoscopy
What is a colonoscopy? Study of lining of colon and rectum by a gastoenterologist Study of lining of colon and rectum by a gastoenterologist.
Virtual Colonoscopy to Screen for Colorectal Cancer Lawrence Fleming, M.D. June 23, 2004.
A CMH Community DocTalk with Robert Wayne, MD, FACS.
D. M. Kruss MD Kill the Cancer Do Screening now! Daniel M. Kruss, M.D. Kill the Cancer Do Screening now! Daniel M. Kruss, M.D.
AIMGP Seminar Series January 2004 Joo-Meng Soh Edited by Gloria Rambaldini CANCER SCREENING PART II.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
COLORECTAL CANCER SCREENING in December of 2002 Jeffrey W. Frank, MD.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
© Copyright Annals of Internal Medicine, 2014 Ann Int Med. 160 (5): ITC5-1. * For Best Viewing: Open in Slide Show Mode Click on icon or From the View.
CURRENT NATIONAL PREVENTIVE HEALTH CARE GUIDELINES Juanita Halls, M.D. Professor of Medicine General Internal Medicine University of Wisconsin - UW Health.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Population Screening for Colorectal Cancer - update of evidences
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
An Evidence Based Approach to Colorectal Cancer Screening J. C. Ryan, M.D. Associate Professor of Medicine UCSF and SF VAMC 9/22/2014.
US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
Barium Enema in the detection of Colon Cancer
Dr. Cynthia Walsh Department of Radiology.  To learn the imaging modality best to SCREEN for Colon Cancer  To learn the imaging modality best to SCREEN.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Organizing Colorectal Cancer.
Screening for Colorectal Cancer (CRC) Nov, 2007 A Aljebreen, FRCPC Division of Gastroenterology KKUH, Riyadh.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
D EPARTMENT of F AMILY M EDICINE Colorectal Cancer Screening: Update on Guidelines and Projects Barcey T. Levy, PhD, MD Professor, Department of Family.
Riva L. Rahl, M.D. Cooper Clinic Preventive Medicine Physician Medical Director, Cooper Wellness Program Cancer: Beating the Odds.
The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has.
Colorectal Cancer Sunil T. Joseph, M.D..  Third leading cause of cancer-related death in U.S. (lung)  112,340 estimated new cases in 2007; 52,000 deaths.
Screening and Prevention of Cancers of the Colon and Pancreas Peter E. Darwin, MD, FACP, FASGE Professor Department of Medicine.
Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
USPSTF Colorectal Cancer Screening Guidelines: What’s New?
Colorectal Cancer Screening Guidelines
27th Annual Winter CME Conference
Colorectal Cancer Screening
VIRTUAL COLONOSCOPY DR DEEPIKA SOLANKI.
Colonoscopy in crc screening
Presentation transcript:

Screening for Colorectal Cancer Bruce D. Greenwald, MD Associate Professor of Medicine University of Maryland School of Medicine and Greenebaum Cancer Center

2003 Estimated US Cancer Cases* ONS=Other nervous system. *Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder. Source: American Cancer Society, Men 675,300 Women 658, ,816Breast 79,056Lung/bronchus 72,468Colon & rectum 39,528Uterine corpus 26,352Ovary 26,352Non-Hodgkin lymphoma 19,764Melanoma of skin 19,764Thyroid 13,176Pancreas 13,176Urinary bladder 62,238All other sites Prostate 222,849 Lung/bronchus 94,542 Colon/rectum 74,283 Urinary bladder 40,518 Melanoma of 27,012 skin Non-Hodgkin 27,012 lymphoma Kidney20,259 Oral cavity 20,259 Leukemia 20,259 Pancreas13,506 All other sites114,801 Men 675,300 Women 658,800

Adenoma – Carcinoma Sequence Normal Adenoma Severe Cancer Mucosa Dysplasia

Colon Polyp

Colon Cancer

Distribution of Colorectal Cancer

Colorectal cancer screening First assess RISK AVERAGE RISK INDIVIDUAL All patients age 50 years and older, the asymptomatic general population HIGH RISK Personal history Family history

Colorectal Cancer Screening Fecal occult blood testing (FOBT) Flexible sigmoidoscopy Barium enema Colonoscopy CT colography Stool genetic testing Average risk

FOBT – Clinical Issues Test 3 consecutive stools Diet modification is necessary OK to test when patient is on low-dose ASA or warfarin in therapeutic range All positives lead to full colon evaluation (colonoscopy) Rehydration leads to higher sensitivity and lower specificity

Annual FOBT Saves Lives! Mandel JS et al. N Engl J Med : % reduction }

Follow-up of Positive FOBT Colonoscopy recommended HOWEVER: Only 52% of primary care physicians would recommend colonoscopy Only 29% of internal medicine residents would recommend colonoscopy Winawer et al. Gastroenterol 1997;112:584 Sharma et al. Am J Gastroenterol 2000;95:1551 Sharma et al. Am J Gastroenterol 2000;95:1914

FOBT Utilization is Poor MMWR Morb Mortal Wkly Rep 2003 Mar 14;52(10): CDC Behavioral Risk Factor Surveillance System

Flexible Sigmoidoscopy PROS: May be done in the office Inexpensive, cost-effective Mortality from rectal cancer reduced by 60-70% in case-control studies Easier bowel preparation, usually done without sedation CONS: Detects only one-half of adenomas 40% of cancers arise proximal to splenic flexure 75% of proximal cancers have no adenomas distal to splenic flexure Often limited by discomfort, poor bowel preparation Selby et al. N Engl J Med 1992;326:653Stewart Aust NZ J Surg 1999;69:2 Rex et al. Gastrointest Endosc 1999;99:727Painter et al. Endoscopy 1999;3:269 Newcomb et al. J Natl Canc Inst 1992;84:1572

Flexible Sigmoidoscopy Misses 50% of Lesions Colonoscopy comparison studies: 46-52% of patient with advanced proximal neoplasia (> 1 cm, villous, high-grade dysplasia or cancer) had no adenomas distal to the splenic flexure Lieberman et al. N Engl J Med 2000; 343: Imperiale et al. N Engl J Med 2000; 343:

Combined FOBT and Sigmoidoscopy Case-control trial (N=21,750) w/rigid sigmoidoscopy – improved survival Other trials: FS + FOBT Improved yield over FOBT alone Adding FOBT to FS alone may not improve yield Winawer et al. J Natl Cancer Inst 1993;85:1311 Pignone et al. Screening for colorectal cancer in adults. * + *p < p = 0.53

FOBT + Flexible Sigmoidoscopy Misses 24% of Lesions Colonoscopy comparison studies: 24.2% of patient with advanced proximal neoplasia (> 1 cm, villous, high-grade dysplasia or cancer) had negative FOBT and no adenomas distal to the splenic flexure. Lieberman and Weiss. N Engl J Med 2001; 345:

Colorectal Cancer Screening: Double-Contrast Barium Enema Colon Cancer

Double-contrast Barium Enema PROS: Low cost, exams whole colon CONS: Never studied as a screening test Missed 50% of adenomas < 1 cm in National Polyp Study Sensitivity for cancer in patients with positive FOBT: 50-75% Poor specificity; best interval unknown Winawer et al. Gastroenterol 1997;112:599 Rex. Endoscopy 1995;27:200 Lieberman et al. N Engl J Med 2000;343:163

Colonoscopy PROS: Exams entire colon Therapeutic – polyps removed at time of procedure CONS: Invasive, risk of complications Requires bowel prep, missed work, escort home Incomplete procedures ~5% Missed polyps Randomized trials lacking

Colonoscopic Polypectomy Reduces Colorectal Cancer Incidence Winawer et al. N Engl J Med 1993; 329:

Miss Rate for Colonoscopy Comparison group Tandem Colonoscopy CT Colography Adenoma  5 mm 27%-- Adenoma 6 – 9 mm13%9% Adenoma  10 mm 6%12% Rex et al. Gastroenterol 1997; 112: Pickhardt et al. N Engl J Med 2003;349:

Colonoscopy Complications Perforation1-2/1000 procedures Bleeding3/1000 procedures Mortality1/10,000 procedures

Endoscopic Screening Rates are Low MMWR Morb Mortal Wkly Rep 2003 Mar 14;52(10): CDC Behavioral Risk Factor Surveillance System

Cost-Effectiveness of Colorectal Cancer Screening Screening method Cost-effectiveness ratio (cost per life-years saved) FOBT annually$ 5,691 - $17,805 Flexible sigmoidoscopy every 5 years $12,477 - $19,068 FOBT annually + flexible sigmoidoscopy every 5 yrs $13,792 - $22,518 Double contrast barium enema every 5 years $11,168 - $25,624 Colonoscopy every 10 yrs$ 9,038 - $22,012 Pignone et al. Ann Int Med 2002;137:

Stool DNA Testing Schwartz. N Engl J Med 2002;346:302-4

Stool DNA Testing Pros No sedation or preparation necessary Home-based (patient mails sample) No risk Cons Low sensitivity of current tests for detection of cancers (50-70%) or polyps (27-74%) Ross. Practical Gastroenterol 2004: Cost (? frequency of exam) Not therapeutic Not covered by insurance

CT Colography/Virtual Colonoscopy Pickhardt et al. N Engl J Med 2003;349: Solitary 16-mm Pedunculated Cecal Polyp in a 55-Year-Old Man at Average Risk for Colorectal Neoplasia

Virtual Colonoscopy Technique 1. Cleanse bowels vigorously Liquid/low fiber diet x hrs Sodium phosphate, PEG or equivalent Bisacodyl tablets + suppository Oral stool tagging optional

Virtual Colonoscopy Technique 2. Inflate colon Old method => 50 hand-bulb squeezes of room air (78% N) New method => Electronic CO2 insufflator

Adequately distended colon crucial

Virtual Colonoscopy Technique 3. Scan Abdomen Multi-detector (4-16 slice) helical CT Scan time: < 20 sec 1-mm slices Scan patient prone and supine

Virtual Colonoscopy Technique 4. Analyze data 2-D image review, 3-D for problem solving or vice versa Split colon, Fillet views Computer-assisted detection

Display on CT Workstation

Virtual Colonoscopy Results are Variable! Pickhardt et al. N Engl J Med 2003;349:2191 Cotton et al. JAMA 2004, 291:1731

Problems with Virtual Colonoscopy Polyps < 8mm difficult Preparation still needed: stool and fluid can simulate/obscure polyps Lack of mucosal detail: flat polyps can be missed (same with colonoscopy) Steep learning curve for radiologist Specialized equipment needed Radiation dose

Strengths of Virtual Colonoscopy No sedation necessary Low risk Fast: 20 min vs. 25 min for colonoscopy (plus 60-min recovery) Detection of extracolonic lesions Option for failed colonoscopy or unsuitable patients

How to Improve Virtual Colonoscopy Well trained readers – Accreditation programs necessary Double read all cases during learning curve Careful attention to technique – well distended colon and good prep Use “State-of-the-Art” workstation and computer-aided diagnosis (CAD) to optimize lesion detection

“If, after the age of fifty, you wake up in the morning and nothing hurts, this is strong evidence that you have died during the night.” - A. Paukner

Colorectal Cancer Screening  Fecal occult blood test (FOBT) every year, or  Flexible sigmoidoscopy every 5 years,or  A fecal occult blood test every year plus flexible sigmoidoscopy every 5 years (recommended by the American Cancer Society), or  Double-contrast barium enema every 5 to 10 years, or  Colonoscopy every 10 years (recommended by the American College of Gastroenterology).